FDA Approved: AMBRISENTAN — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for Ambrisentan as a generic version, for treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (generic) (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)